Navigation Links
BMC to protect its rights in patent fight with ResMed
Date:12/12/2013

BEIJING, Dec. 12, 2013 /PRNewswire/ -- BMC Medical Co., Ltd (BMC) is a specialist of sleep diagnosis and therapy and headquartered in China. On 11 November 2013, right before the commencement of the MEDICA trade show in Düsseldorf, Germany, ResMed filed applications for preliminary injunctions against BMC with the District Court Munich I, Germany, prohibiting BMC from selling or marketing certain products in Germany including BMC's RESmart CPAP devices and BMC's Willow/FeaLite nasal pillows.

(Logo: http://www.prnasia.com/sa/2013/12/05/20131205202544523773.jpg

Dr. Ulrich Worm, head of IP Germany and Partner of global law firm Mayer Brown, retained by BMC to represent BMC in the patent fight, points out: "The preliminary injunctions are issued as a result of ex parte proceedings, which means that the court did not hear, and could not take into account of, BMC's side of the story. Until now, no court hearing has been conducted."

James Xu, General Manager of BMC, states: "We will take all the measures required to defend our IP and products, thus protecting our consumer and business interests against the preliminary injunctions."

In the same vein, in July of this year, ResMed initiated two legal proceedings in the U.S. at the ITC and the Federal District Court of Southern California, alleging that BMC infringed its patents. BMC has retained a noted ITC 337 and patent specialist, Gary Hnath of Mayer Brown to fully contest the proceedings. Gary Hnath has indicated that he is confident that BMC will be able to demonstrate that each patent asserted by ResMed in the U.S. is either not infringed, invalid, or both.

About BMC

BMC Medical Co., Ltd is a specialist of sleep diagnosis and therapy, with continuous product research and development, constant innovation, aiming at providing best respiratory homecare and service. For more information on BMC, visit http://en.bmc-medical.com.


'/>"/>
SOURCE BMC Medical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
3. Broad Patent Protection Granted for iBio Immunomodulator
4. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
5. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
6. China Botanic Sponsors Wild Plant Protection Association of China Meeting; Expects to Lead the Siberian Ginseng Conservation Association
7. Ivera Medical Announces Patent Award for Curos® Port Protectors
8. Burlington Medical Supplies Offers No Fog Eyewear For X-Ray Protection
9. Protected Classes Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
10. Government Affairs Groups Play Critical Role in Protecting Organizations in Turbulent Times
11. Family Research Council: Newland Family Offered Temporary Protection from Obamas Abortion Drug Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... -- The Mobile X-Ray product segment is the most attractive ... forecast period Mobile X-Ray segment is the largest ... devices market, which is estimated to be valued at more ... of 7% over the forecast period. Mobile X-Ray segment is ... 100 Mn in 2017 over 2016. The segment,s revenue in ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
(Date:4/21/2017)... Colo. (PRWEB) , ... April 21, 2017 , ... The ... the Flex House, the next project in the company’s esteemed VISION House demonstration project ... homeowners use exactly the amount of resources they need to live affordably and abundantly ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility in ... Kong to support teaching, learning and research. It is also the largest research centre ... Kong. , With an area of 620 square metres and more than 50 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens ... of International Trade, the UK’s most prestigious award for business success. The ... of total revenues and has grown by a total of 400% over the ...
Breaking Medicine News(10 mins):